White blood cell counts as risk markers of developing metabolic syndrome and its components in the PREDIMED study.
<h4>Background</h4>The Metabolic Syndrome (MetS) is a cluster of metabolic abnormalities that includes hyperglucemia, hypertension, dyslipidemia and central obesity, conferring an increased risk of cardiovascular disease. The white blood cell (WBC) count has been proposed as a marker for...
Guardado en:
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2013
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/f1f067a6591d409c90ac2c006058357c |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:f1f067a6591d409c90ac2c006058357c |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:f1f067a6591d409c90ac2c006058357c2021-11-18T07:52:59ZWhite blood cell counts as risk markers of developing metabolic syndrome and its components in the PREDIMED study.1932-620310.1371/journal.pone.0058354https://doaj.org/article/f1f067a6591d409c90ac2c006058357c2013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23526980/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>The Metabolic Syndrome (MetS) is a cluster of metabolic abnormalities that includes hyperglucemia, hypertension, dyslipidemia and central obesity, conferring an increased risk of cardiovascular disease. The white blood cell (WBC) count has been proposed as a marker for predicting cardiovascular risk. However, few prospective studies have evaluated the relationship between WBC subtypes and risk of MetS.<h4>Methods</h4>Participants were recruited from seven PREDIMED study centers. Both a baseline cross-sectional (n = 4,377) and a prospective assessment (n = 1,637) were performed. Participants with MetS at baseline were excluded from the longitudinal analysis. The median follow-up was 3.9 years. Anthropometric measurements, blood pressure, fasting glucose, lipid profile and WBC counts were assessed at baseline and yearly during the follow-up. Participants were categorized by baseline WBC and its subtype count quartiles. Adjusted logistic regression models were fitted to assess the risk of MetS and its components.<h4>Results</h4>Of the 4,377 participants, 62.6% had MetS at baseline. Compared to the participants in the lowest baseline sex-adjusted quartile of WBC counts, those in the upper quartile showed an increased risk of having MetS (OR, 2.47; 95%CI, 2.03-2.99; P-trend<0.001). This association was also observed for all WBC subtypes, except for basophils. Compared to participants in the lowest quartile, those in the top quartile of leukocyte, neutrophil and lymphocyte count had an increased risk of MetS incidence. Leukocyte and neutrophil count were found to be strongly associated with the MetS components hypertriglyceridemia and low HDL-cholesterol. Likewise, lymphocyte counts were found to be associated with the incidence of the MetS components low HDL-cholesterol and high fasting glucose. An increase in the total WBC during the follow-up was also associated with an increased risk of MetS.<h4>Conclusions</h4>Total WBC counts, and some subtypes, were positively associated with MetS as well as hypertriglyceridemia, low HDL-cholesterol and high fasting glucose, all components of MetS.<h4>Trial registration</h4>Controlled-Trials.comISRCTN35739639.Nancy BabioNúria Ibarrola-JuradoMònica BullóMiguel Ángel Martínez-GonzálezJulia WärnbergItziar SalaverríaManuel Ortega-CalvoRamón EstruchLluís Serra-MajemMaria Isabel CovasJosé Vicente SorliJordi Salas-SalvadóPREDIMED Study InvestigatorsPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 3, p e58354 (2013) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Nancy Babio Núria Ibarrola-Jurado Mònica Bulló Miguel Ángel Martínez-González Julia Wärnberg Itziar Salaverría Manuel Ortega-Calvo Ramón Estruch Lluís Serra-Majem Maria Isabel Covas José Vicente Sorli Jordi Salas-Salvadó PREDIMED Study Investigators White blood cell counts as risk markers of developing metabolic syndrome and its components in the PREDIMED study. |
| description |
<h4>Background</h4>The Metabolic Syndrome (MetS) is a cluster of metabolic abnormalities that includes hyperglucemia, hypertension, dyslipidemia and central obesity, conferring an increased risk of cardiovascular disease. The white blood cell (WBC) count has been proposed as a marker for predicting cardiovascular risk. However, few prospective studies have evaluated the relationship between WBC subtypes and risk of MetS.<h4>Methods</h4>Participants were recruited from seven PREDIMED study centers. Both a baseline cross-sectional (n = 4,377) and a prospective assessment (n = 1,637) were performed. Participants with MetS at baseline were excluded from the longitudinal analysis. The median follow-up was 3.9 years. Anthropometric measurements, blood pressure, fasting glucose, lipid profile and WBC counts were assessed at baseline and yearly during the follow-up. Participants were categorized by baseline WBC and its subtype count quartiles. Adjusted logistic regression models were fitted to assess the risk of MetS and its components.<h4>Results</h4>Of the 4,377 participants, 62.6% had MetS at baseline. Compared to the participants in the lowest baseline sex-adjusted quartile of WBC counts, those in the upper quartile showed an increased risk of having MetS (OR, 2.47; 95%CI, 2.03-2.99; P-trend<0.001). This association was also observed for all WBC subtypes, except for basophils. Compared to participants in the lowest quartile, those in the top quartile of leukocyte, neutrophil and lymphocyte count had an increased risk of MetS incidence. Leukocyte and neutrophil count were found to be strongly associated with the MetS components hypertriglyceridemia and low HDL-cholesterol. Likewise, lymphocyte counts were found to be associated with the incidence of the MetS components low HDL-cholesterol and high fasting glucose. An increase in the total WBC during the follow-up was also associated with an increased risk of MetS.<h4>Conclusions</h4>Total WBC counts, and some subtypes, were positively associated with MetS as well as hypertriglyceridemia, low HDL-cholesterol and high fasting glucose, all components of MetS.<h4>Trial registration</h4>Controlled-Trials.comISRCTN35739639. |
| format |
article |
| author |
Nancy Babio Núria Ibarrola-Jurado Mònica Bulló Miguel Ángel Martínez-González Julia Wärnberg Itziar Salaverría Manuel Ortega-Calvo Ramón Estruch Lluís Serra-Majem Maria Isabel Covas José Vicente Sorli Jordi Salas-Salvadó PREDIMED Study Investigators |
| author_facet |
Nancy Babio Núria Ibarrola-Jurado Mònica Bulló Miguel Ángel Martínez-González Julia Wärnberg Itziar Salaverría Manuel Ortega-Calvo Ramón Estruch Lluís Serra-Majem Maria Isabel Covas José Vicente Sorli Jordi Salas-Salvadó PREDIMED Study Investigators |
| author_sort |
Nancy Babio |
| title |
White blood cell counts as risk markers of developing metabolic syndrome and its components in the PREDIMED study. |
| title_short |
White blood cell counts as risk markers of developing metabolic syndrome and its components in the PREDIMED study. |
| title_full |
White blood cell counts as risk markers of developing metabolic syndrome and its components in the PREDIMED study. |
| title_fullStr |
White blood cell counts as risk markers of developing metabolic syndrome and its components in the PREDIMED study. |
| title_full_unstemmed |
White blood cell counts as risk markers of developing metabolic syndrome and its components in the PREDIMED study. |
| title_sort |
white blood cell counts as risk markers of developing metabolic syndrome and its components in the predimed study. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2013 |
| url |
https://doaj.org/article/f1f067a6591d409c90ac2c006058357c |
| work_keys_str_mv |
AT nancybabio whitebloodcellcountsasriskmarkersofdevelopingmetabolicsyndromeanditscomponentsinthepredimedstudy AT nuriaibarrolajurado whitebloodcellcountsasriskmarkersofdevelopingmetabolicsyndromeanditscomponentsinthepredimedstudy AT monicabullo whitebloodcellcountsasriskmarkersofdevelopingmetabolicsyndromeanditscomponentsinthepredimedstudy AT miguelangelmartinezgonzalez whitebloodcellcountsasriskmarkersofdevelopingmetabolicsyndromeanditscomponentsinthepredimedstudy AT juliawarnberg whitebloodcellcountsasriskmarkersofdevelopingmetabolicsyndromeanditscomponentsinthepredimedstudy AT itziarsalaverria whitebloodcellcountsasriskmarkersofdevelopingmetabolicsyndromeanditscomponentsinthepredimedstudy AT manuelortegacalvo whitebloodcellcountsasriskmarkersofdevelopingmetabolicsyndromeanditscomponentsinthepredimedstudy AT ramonestruch whitebloodcellcountsasriskmarkersofdevelopingmetabolicsyndromeanditscomponentsinthepredimedstudy AT lluisserramajem whitebloodcellcountsasriskmarkersofdevelopingmetabolicsyndromeanditscomponentsinthepredimedstudy AT mariaisabelcovas whitebloodcellcountsasriskmarkersofdevelopingmetabolicsyndromeanditscomponentsinthepredimedstudy AT josevicentesorli whitebloodcellcountsasriskmarkersofdevelopingmetabolicsyndromeanditscomponentsinthepredimedstudy AT jordisalassalvado whitebloodcellcountsasriskmarkersofdevelopingmetabolicsyndromeanditscomponentsinthepredimedstudy AT predimedstudyinvestigators whitebloodcellcountsasriskmarkersofdevelopingmetabolicsyndromeanditscomponentsinthepredimedstudy |
| _version_ |
1718422827558764544 |